Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Clinical trial NCT02718326 · COMPLETED
Trial details
- NCT number
- NCT02718326
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-29
- Primary completion
- 2018-08-06
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.